CVE-2026-9844Vulnerability in navify® Digital Pathology
Updated under an hour ago ()
Does this affect you?
It affects Roche Diagnostics navify Digital Pathology. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.41%, higher than 34% of scored CVEs.
Do this next
Free account, 1 product
Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.
- CVSS
- 8.8 HIGH (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:L/SI:L/SA:L/S:N/AU:Y/R:U/V:D/RE:M/U:Green
- Weakness (CWE)
- CWE-1392
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.41% (percentile 34)
- Assigned by
- Roche
- NVD analysis
- Deferred
- Record last updated
- Jun 2, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Roche Diagnostics navify Digital Pathology roche_diagnostics:navify_digital_pathology (from the name) | from 2.0.0 through 2.4.1 | CNA record |
References
- https://diagnostics.roche.com/global/en/legal/product-security-advisory.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.